Skip to main content

Table 2 Kawasaki features and associated symptoms of Kawasaki disease shock syndrome and Kawasaki disease

From: Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study

  KDSS(n=13) KD(n=91) P value
Kawasaki features
 Conjunctival injection 92.3% (12/13) 91.2% (83/91) 1.000
 Oropharyngeal changes 84.6% (11/13) 81.3% (74/91) 1.000
 Polymorphous rash 76.9% (10/13) 84.6% (77/91) 0.442
 Cervical lymphadenopathy 69.2% (9/13) 44.0% (40/91) 0.088
 Extremity changes 92.3% (12/13) 67.0% (61/91) 0.102
Associated symptoms
 Gastrointestinal symptoms 84.6% (11/13) 26.4% (24/91) 0.000
 Respiratory symptoms 76.9% (10/13) 9.9% (9/91) 0.000
 Neurologic symptoms 15.4% (2/13) 2.2% (2/91) 0.066
 Systemic pain 53.8% (7/13) 3.3% (3/91) 0.000
Pleural effusion 76.9% (10/13) 2.2% (2/91) 0.000
Organ damage 92.3% (12/13) 20.9%(19/91) 0.000
  1. KD Kawasaki disease, KDSS Kawasaki disease shock syndrome, SS Septic shock and toxic shock syndrome